Abstract

BackgroundResearch grade Fresh Frozen (FF) DNA material is not yet routinely collected in clinical practice. Many hospitals, however, collect and store Formalin Fixed Paraffin Embedded (FFPE) tumor samples. Consequently, the sample size of whole genome cancer cohort studies could be increased tremendously by including FFPE samples, although the presence of artefacts might obfuscate the variant calling. To assess whether FFPE material can be used for cohort studies, we performed an in-depth comparison of somatic SNVs called on matching FF and FFPE Whole Genome Sequence (WGS) samples extracted from the same tumor.MethodsFour variant callers (i.e. Strelka2, Mutect2, VarScan2 and Shimmer) were used to call somatic variants on matching FF and FFPE WGS samples from a metastatic prostate tumor. Using the variants identified by these callers, we developed a heuristic to maximize the overlap between the FF and its FFPE counterpart in terms of sensitivity and precision. The proposed variant calling approach was then validated on nine matched primary samples. Finally, we assessed what fraction of the discrepancy could be attributed to intra-tumor heterogeneity (ITH), by comparing the overlap in clonal and subclonal somatic variants.ResultsWe first compared variants between an FF and an FFPE sample from a metastatic prostate tumor, showing that on average 50% of the calls in the FF are recovered in the FFPE sample, with notable differences between callers. Combining the variants of the different callers using a simple heuristic, increases both the precision and the sensitivity of the variant calling. Validating the heuristic on nine additional matched FF-FFPE samples, resulted in an average F1-score of 0.58 and an outperformance of any of the individual callers. In addition, we could show that part of the discrepancy between the FF and the FFPE samples can be attributed to ITH.ConclusionThis study illustrates that when using the correct variant calling strategy, the majority of clonal SNVs can be recovered in an FFPE sample with high precision and sensitivity. These results suggest that somatic variants derived from WGS of FFPE material can be used in cohort studies.

Highlights

  • Research grade Fresh Frozen (FF) Deoxyribonucleic Acid (DNA) material is not yet routinely collected in clinical practice

  • To ensure that comparing the somatic variants called from the matching FF and Formalin Fixed Paraffin Embedded (FFPE) samples would be independent of the specificities of the variant caller, we used four somatic variant callers, i.e. Strelka2 [15], Mutect2 [16], VarScan2 [18] and Shimmer [17]

  • In this study we aimed at investigating the feasibility of somatic Single Nucleotide Variation (SNV) calling in FFPE material

Read more

Summary

Introduction

Research grade Fresh Frozen (FF) DNA material is not yet routinely collected in clinical practice. To assess whether FFPE material can be used for cohort studies, we performed an in-depth comparison of somatic SNVs called on matching FF and FFPE Whole Genome Sequence (WGS) samples extracted from the same tumor. Exploiting available patients’ cohorts would require collecting sequence information from FFPE samples that are collected in routine standard of care for histopathological diagnosis. This poses a problem as DNA extracted from FFPE specimens presents degradation such as nucleic acid fragmentation, DNA crosslinks, abasic sites leading to localized DNA denaturation, strand breaks, and deamination leading to C > T mutations [1,2,3]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call